Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by impaired memory, cognition and altered behavior. Aging increases the incidence of AD from ∼10% in people 65 years of age or older to ∼47% in persons > 85 years. Although many theories have been proposed regarding the etiology of AD, the exact mechanisms involved are unknown and no effective cure exists. Exploring the role of calcium (Ca2+) in AD has begun to offer some insight into this devastating disease. This review will provide a basic background into AD pathology and genetics, followed by a more in depth focus on the evidence linking altered Ca2+ regulation to both the early-onset AD gene products and actual affected tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berridge, M.J., 1998, Neuronal calcium signaling, Neuron 21, 13–26.
Bootman, M.D. and Berridge, M.J., 1995, The elemental principles of calcium signaling, Cell 83, 675–678.
Braak, H. and Braak, E., 1991, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol. 82, 239–259.
Buxbaum, J.D., Choi, E.-K., Luo, Y., Lilliehook, C., Crowley, A.C., Merriam, D.E. and Wasco, W., 1998, Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment, Nature Med. 4, 1177–1181.
Carrion, A.M., Link, W.A., Ledo, F., Mellstrom, B. and Naranjo, J.R., 1999, DREAM is a Ca2+-regulated transcriptional repressor, Nature 398, 80–84.
Clapham, D.E., 1995, Calcium signaling, Cell 80, 259–268.
Cotman, C.W., 1998, Apoptosis decision cascades and neuronal degeneration in Alzheimer’s disease, Neurobiol Aging 19, S29–S32.
Donoviel, D.B., Hadjantonakis, A.K., Ikeda, M., Zheng, H., Hyslop, P.S. and Bernstein, A., 1999, Mice lacking both presenilin genes exhibit early embryonic patterning defects, Genes Dev. 13,2801–2810.
Etcheberrigaray, R., Hirashima, N., Nee, L., Prince, J., Govoni, S., Racchi, M., Tanzi, R.E. and Alkon, D.L., 1998, Calcium responses in fibroblasts from asymptomatic members of Alzheimer’s disease families, Neurobiol. Dis. 5, 37–45.
Gervais, pEG., Xu, D., Robertson, G.S., Vaillancourt, J.P., Zhu, Y, Huang, J., LeBlanc, A., Smith, D., Rigby, M, Shearman, M.S., Clarke, E.E., Zheng, H., Van Der Ploeg, L.H., Ruffolo, S.C., Thornberry, N.A., Xanthoudakis, S., Zamboni, R.J., Roy, S. and Nicholson, D.W., 1999, Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation, Cell 97, 395–406.
Gibson, G.E., Vestling, M., Zhang, H., Szolosi, S., Alkon, D., Lannfelt, L., Gandy, S. and Cowburn, R.F., 1997, Abnormalities in Alzheimer’s disease fibroblasts bearing the APP670/671 mutation, Neurobiol Aging 18, 573–580.
Guo, Q., Furukawa, K., Sopher, B.L., Pham, D.G., Xie, J., Robinson, N., Martin, G.M. and Mattson, M.P., 1996, Alzheimer’s PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide, Neuroreport 8, 379–383.
Guo, Q., Sopher, B.L., Furukawa, K., Pham, D.G., Robinson, N., Martin, G.M. and Mattson, M.P., 1997, Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals, J. Neurosci. 17, 4212–4222.
Guo, Q., Christakos, S., Robinson, N. and Mattson, M.P., 1998, Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function, Proc. Natl. Acad. Sci. USA 95, 3227–3232.
Haass, C. and De Strooper, B., 1999, The presenilins in Alzheimer’s disease-proteolysis hold the key, Science 286, 916–919.
Hardy, J., 1997, Amyloid, the presenilins and Alzheimer’s disease, Trends Neurosci. 20, 154–159.
Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Semeeis, L., Umans, L., Schrijvers, V., Checler, E., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., Van Leuven, F. and De Strooper, B., 1999, Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency, Proc. Natl Acad. Sci. USA 96, 11872–11877.
Hirashima, N., Etcheberrigaray, R., Bergamaschi, S., Racchi, M., Battaini, F., Binetti, G., Govoni, S. and Alkon, D.L., 1996, Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer’s disease, Neurobiol Aging 17, 549–555.
Ito, E., Oka, K., Etcheberrigaray, R., Nelson, T.J., McPhie, D.L., Tofel-Grehl, B., Gibson, G.E. and Alkon, D.L., 1994, Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease, Proc. Natl Acad. Sci. USA 91, 534–538.
Janicki, S. and Monteiro, M.J., 1997, Increased apoptosis arising from increased expression of the Alzheimer’s disease-associated presenilin-2 mutation (N141I), J. Cell Biol. 139, 485–495.
Janicki, S.M. and Monteiro, M.J., 1999, Presenilin overexpression arrests cells in the Gl phase of the cell cycle. Arrest potentiated by the Alzheimer’s disease PS2(N14II) mutant, Am. J. Pathol. 155, 135–144.
Kauselmann, G., Weiler, M., Wulff, P., Jessberger, S., Konietzko, U., Scafidi, J., Staubli, U., Bereiter-Hahn, J., Strebhardt, K. and Kuhl, D., 1999, The polo-like protein kinases Fnk and Snk associate with a Ca(2+)-and integrin-binding protein and are regulated dynamically with synaptic plasticity, EMBO J. 18, 5528–5539.
Kelliher, M., Fastbom, J., Cowburn, R.F., Bonkale, W., Ohm, T.G., Ravid, R., Sorrentino, V. and O’Neill, C, 1999, Alterations in the ryanodine receptor calcium release chan-nel correlate with Alzheimer’s disease neurofibrillary and beta-amyloid pathologies, Neuroscience 92, 499–513.
Leissring, M.A., Paul, B.A., Parker, I., Cotman, C.W. and LaFerla, F.M., 1999, Alzheimer’s presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes, J. Neurochem. 72, 1061–1068.
Leissring, M.A., Parker, I. and LaFerla, F.M., 1999, Presenilin-2 mutations modulate amp-litude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals, J. Biol Chem. 274, 32535–32538.
Mattson, M.P., 1997, Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives, Physiol Rev. 11, 1081–1132.
Mattson, M.P. and Guo, Q., 1999, The presenilins, The Neuro scientist 5, 112–124.
McCoy, K.R., Mullins, R.D., Newcomb, T.G., Ng, G.M., Pavlinkova, G., Polinsky, R.J., Nee, L.E. and Sisken, J.E., 1993, Serum-and bradykinin-induced calcium transients in familial Alzheimer’s fibroblasts, Neurobiol Aging 14, 447–455.
Mikkonen, M., Alafuzoff, I., Tapiola, T., Soininen, H. and Miettinen, R., 1999, Subfield-and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer’s disease, Neuroscience 92, 515–532.
Naik, U.P., Patel, P.M. and Parise, L.V., 1997, Identification of a novel calcium-binding protein that interacts with the integrin alphallb cytoplasmic domain, J. Biol. Chem. 272, 4651–4654.
Neve, R.L. and Robakis, N.K., 1998, Alzheimer’s disease: A re-examination of the amyloid hypothesis, Trends Neurosci. 21, 15–19.
Nishimoto, I., 1998, A new paradigm for neurotoxicity by FAD mutants of betaAPP: A signaling abnormality, Neurobiol Aging 19, S33–S38.
Pack-Chung, E., Myers, M.B., Pettingell, W.P., Cheng, I., Moir, R.D., Brownawell, A.M., Tanzi, R.E. and Kim, T.-W., 2000, Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor, J. Biol. Chem. 275, 14440–14445.
Parkin, E.T., Hussain, I., Karran, E.H., Turner, A.J. and Hooper, N.M., 1999, Characterization of detergent-insoluble complexes containing the familial Alzheimer’s disease-associated presenilins, J. Neurochem. 72, 1534–1543.
Pollard, H.B., Arispe, N. and Rojas, E., 1995, Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity, Cell Mol. Neurobiol. 15, 513–526.
Price, D.L., Tanzi, R.E., Borchelt, D.R. and Sisodia, S.S., 1998, Alzheimer’s disease: genetic studies and transgenic models, Ann. Rev. Genet. 32, 461–4193.
Querfurth, H.W. and Selkoe, D.J., 1994, Calcium ionophore increases amyloid beta peptide production by cultured cells, Biochemistry 33, 4550–4561.
Querfurth, H.W., Jiang, J., Geiger, J.D. and Selkoe, D.J., 1997, Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells, J. Neurochem. 69, 1580–1591.
Raina, A.K., Monteiro, M.J., McShea, A. and Smith, M.A., 1999, The role of cell cycle-mediated events in Alzheimer’s disease, Int. J. Exp. Pathol. 80, 71–76.
Saito, T., Seki, N., Hattori, A., Hayashi, A., Abe, M., Araki, R., Fujimori, A., Fukumura, R., Kozuma, S. and Matsuda, Y, 1999, Structure, expression profile, and chromosomal location of a mouse gene homologous to human DNA-PKcs interacting protein (KIP) gene, Mamm. Genome 10, 315–317.
Seki, N., Hayashi, A., Abe, M., Araki, R., Fujimori, A., Fukumura, R., Hattori, A., Kozuma, S., Ohhira, M., Hori, T. and Saito, T., 1998, Chromosomal assignment of the gene for human DNA-PKcs interacting protein (KIP) on chromosome 15q25.3-q26.1 by somatic hybrid analysis and fluorescence in situ hybridization, J. Hum. Genet. 43, 275–277.
Seki, N., Hattori, A., Hayashi, A., Kozuma, S., Ohira, M., Hori, T. and Saito, T., 1999, Struc-ture, expression profile and chromosomal location of an isolog of DNA-PKcs interacting protein (KIP) gene, Biochim. Biophys. Acta 1444, 143–147.
Selkoe, DJ., 1998, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer’s disease, Trends Cell Biol. 8, 447–453.
Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al., 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease, Nature 375, 754–760.
Shock, D.D., Naik, U.P., Brittain, J.E., Alahari, S.K., Sondek, J. and Parise, L.V., 1999, Calcium-dependent properties of CIB binding to the integrin alphallb cytoplasmic domain and translocation to the platelet cytoskeleton, Biochem. J. 342, 729–735.
Snyder, S.H., Lai, M.M. and Burnett, P.E., 1998, Immunophilins in the nervous system, Neuron 21, 283–294.
Solodkin, A., Veldhuizen, S.D. and Van Hoesen, G.W., 1996, Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer’s disease, J. Neurosci. 16, 3311–3321.
Stabler, S.M., Ostrowski, L.L., Janicki, S.M. and Monteiro, M.J., 1999, A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer’s disease presenilin 2 protein, J. Cell Biol. 145, 1277–1292.
Stadelmann, C., Deckwerth, T.L., Srinivasan, A., Bancher, C., Bruck, W., Jellinger, K. and Lassmann, H., 1999, Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease. Evidence for apoptotic cell death, Am. J. Pathol. 155, 1459–1466.
Steiner, H., Capell, A., Pesold, B., Citron, M., Kloetzel, P.M., Selkoe, D.J., Romig, H., Mendia, K. and Haass, C, 1998, Expression of Alzheimer’s disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation, J. Biol. Chem. 273, 32322–32331.
Valdivia, H.H., 1998, Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors, Trends Pharmacol. Sci. 19, 479–482.
Vallar, L., Melchior, C., Plancon, S., Drobecq, H., Lippens, G., Regnault, V. and Kieffer, N., 1999, Divalent cations differentially regulate integrin alphallb cytoplasmic tail binding to beta3 and to calcium-and integrin-binding protein, J. Biol Chem. 274, 17257–17266.
Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, R., Teplow, D.B., Ross, S., Amarante, R., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G. and Citron, M., 1999, Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286, 735–741.
Vito, P., Wolozin, B., Ganjei, J.K., Iwasaki, K., Lacana, E. and D’Adamio, L.D., 1996, Re-quirement of the familial Alzheimer’s disease gene PS2 for apoptosis, J. Biol, Chem. 271, 31025–31028.
Wu, X. and Lieber, M.R., 1997, Interaction between DNA-dependent protein kinase and a novel protein, KIP, Mutat. Res. 385, 13–20.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Monteiro, M.J., Stabler, S.M. (2000). Genetic Factors and the Role of Calcium in Alzheimer’s Disease Pathogenesis. In: Pochet, R., Donato, R., Haiech, J., Heizmann, C., Gerke, V. (eds) Calcium: The Molecular Basis of Calcium Action in Biology and Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0688-0_35
Download citation
DOI: https://doi.org/10.1007/978-94-010-0688-0_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6422-1
Online ISBN: 978-94-010-0688-0
eBook Packages: Springer Book Archive